0001140361-20-015434.txt : 20200706
0001140361-20-015434.hdr.sgml : 20200706
20200706171845
ACCESSION NUMBER: 0001140361-20-015434
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200623
FILED AS OF DATE: 20200706
DATE AS OF CHANGE: 20200706
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: King Michael N.
CENTRAL INDEX KEY: 0001816304
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37568
FILM NUMBER: 201014311
MAIL ADDRESS:
STREET 1: 303A COLLEGE ROAD EAST
CITY: PRINCETON
STATE: NJ
ZIP: 08540
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PDS Biotechnology Corp
CENTRAL INDEX KEY: 0001472091
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 264231384
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 25B VREELAND ROAD
CITY: FLORHAM PARK
STATE: NJ
ZIP: 07932
BUSINESS PHONE: 800-208-3343
MAIL ADDRESS:
STREET 1: 25B VREELAND ROAD
CITY: FLORHAM PARK
STATE: NJ
ZIP: 07932
FORMER COMPANY:
FORMER CONFORMED NAME: Edge Therapeutics, Inc.
DATE OF NAME CHANGE: 20090911
3
1
form3.xml
FORM 3
X0206
3
2020-06-23
0
0001472091
PDS Biotechnology Corp
PDSB
0001816304
King Michael N.
C/O PDS BIOTECHNOLOGY CORPORATION
25B VREELAND ROAD
FLORHAM PARK
NJ
07932
true
Interim Chief Financial Office
Employee Stock Option (Right to Buy)
6.87
2019-03-15
2024-12-15
Common Stock
52934
D
Employee Stock Option (Right to Buy)
9.04
2019-03-14
2029-03-14
Common Stock
44871
D
On December 15, 2014, the date of grant, the option was subject to the following vesting schedule: 16,227 options vested on the date of grant and on each monthly anniversary of the date of grant, 1/24 of the options vested. On March 15, 2019, in connection with the merger between the Issuer and private PDS Biotechnology Corporation, the option was accelerated and the shares underlying the option became fully vested and immediately exercisable.
The option was fully vested and immediately exercisable on the date of grant.
/s/ Michael N. King
2020-07-06